In our NASH mice, we observed an increased vascular neointima formation consisting of dedifferentiated vascular smooth muscle cells (SMCs), which was significantly attenuated by topiroxostat, a selective XOR inhibitor. The gene discussed is XDH; the disease is metabolic dysfunction-associated steatohepatitis.